Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16646-42-7

Post Buying Request

16646-42-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16646-42-7 Usage

Carboxylic acid

Functional group
1-Methyl-3-cyclohexenecarboxylic acid is a type of carboxylic acid, which means it contains a carboxyl functional group (-COOH).

Cyclohexene ring

Structure
The compound contains a cyclohexene ring, which is a six-membered carbon ring with alternating single and double bonds.

Methyl group attachment

Substitution
A methyl group (-CH3) is attached to the cyclohexene ring, contributing to the compound's structure and properties.

Pharmaceutical industry use

Intermediate compound
1-Methyl-3-cyclohexenecarboxylic acid is commonly used as an intermediate in the synthesis of other organic compounds, particularly in the production of drugs and pharmaceuticals.

Applications in medications

Anti-inflammatory and analgesic drugs
The compound is used in the manufacturing of various medications, including those with anti-inflammatory and analgesic properties.

Agricultural research potential

Pesticide or herbicide
1-Methyl-3-cyclohexenecarboxylic acid has potential uses in the field of agricultural research as a possible pesticide or herbicide.

Safety concerns

Toxicity and reactivity

Synthesis and applications

Pharmaceutical compounds and other fields
1-Methyl-3-cyclohexenecarboxylic acid plays an important role in the synthesis of pharmaceutical compounds and has potential applications in various other fields.

Check Digit Verification of cas no

The CAS Registry Mumber 16646-42-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,6,4 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 16646-42:
(7*1)+(6*6)+(5*6)+(4*4)+(3*6)+(2*4)+(1*2)=117
117 % 10 = 7
So 16646-42-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H12O2/c1-8(7(9)10)5-3-2-4-6-8/h2-3H,4-6H2,1H3,(H,9,10)

16646-42-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methylcyclohex-3-ene-1-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Methyl-3-cyclohexene-1-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16646-42-7 SDS

16646-42-7Relevant articles and documents

-

Roberts,Jeydel,Armstrong

, p. 3248 (1949)

-

Inhibitors of influenza viruses replication

-

Page/Page column 389, (2016/06/14)

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

INHIBITORS OF INFLUENZA VIRUSES REPLICATION

-

, (2012/07/14)

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16646-42-7